Analyst Ratings For Amphastar Pharmaceuticals (NASDAQ:AMPH)
Today, BMO Capital Markets raised its price target on Amphastar Pharmaceuticals (NASDAQ:AMPH) to $19.00 per share.
Some recent analyst ratings include
- 1/30/2018-Piper Jaffray Companies Reiterated Rating of Buy.
- 11/9/2017-Raymond James Financial was Downgraded by analysts at Raymond James Financial from a “Outperform ” rating to a ” Market Perform” rating. They now have a $18.00 price target on the stock.
- 7/22/2017-Wells Fargo & Co Reiterated Rating of Buy.
Recent Insider Trading Activity For Amphastar Pharmaceuticals (NASDAQ:AMPH)
Amphastar Pharmaceuticals (NASDAQ:AMPH) has insider ownership of 11.10% and institutional ownership of 44.82%.
- On 1/26/2018 Jason B. Shandell, Insider, sold 18,627 with an average share price of $19.42 per share and the total transaction amounting to $361,736.34.
- On 1/25/2018 Jason B. Shandell, General Counsel, sold 8,661 with an average share price of $19.26 per share and the total transaction amounting to $166,810.86.
- On 12/19/2017 Diane G Gerst, EVP, sold 523 with an average share price of $19.48 per share and the total transaction amounting to $10,188.04.
- On 12/14/2017 Stephen B Shohet, Director, sold 7,866 with an average share price of $18.87 per share and the total transaction amounting to $148,431.42.
- On 12/12/2017 Diane G Gerst, EVP, sold 523 with an average share price of $18.96 per share and the total transaction amounting to $9,916.08.
- On 12/7/2017 Stephen B Shohet, Director, sold 7,862 with an average share price of $18.34 per share and the total transaction amounting to $144,189.08.
- On 12/1/2017 William J. Peters, CFO, sold 6,226 with an average share price of $19.67 per share and the total transaction amounting to $122,465.42.
Recent Trading Activity for Amphastar Pharmaceuticals (NASDAQ:AMPH)
Shares of Amphastar Pharmaceuticals closed the previous trading session at with 19.579999923706055 shares trading hands.